NCT04304950View on ClinicalTrials.gov

Chronotherapy in Inflammatory Bowel Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 25, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

April 30, 2023

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

Evening Group

Participants will take their IBD medication (either azathioprine or 6-mercaptopurine) between 6:00 pm and 11:00 pm.

DRUG

Morning Group

Participants will take their IBD medication (either azathioprine or 6-mercaptopurine) between 6:00 am and 11:00 am.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT04304950 - Chronotherapy in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter